Coronary Artery Disease. We see you. 2026 Chair and CEO Annual General Meeting Address and Presentation PERTH, Australia, 13 November 2026: Artrya Limited (ASX: AYA) (Artrya or the Company), a medical technology ® company commercialising its Salix AI-powered cloud platform, for the real time,...
AGM Chairmans Address and CEO Presentation
Filed with ASX · · 25 pages · English
Summary by 6ix AI
Artrya Limited has released the Chair and CEO's address and presentation for its Annual General Meeting, detailing the company's progress and future plans in the medical technology sector focused on coronary artery disease management. The Chair highlighted significant commercial traction, including multi-year contracts with five U.S. health systems and the integration of their Salix® platform to enhance patient care. The CEO's presentation emphasized the growing market opportunity and the company's strategic priorities for the upcoming year, including expanding customer bases and increasing scan volumes.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
In the deck
Story so far
Earlier from Artrya
- Five Yr Agreement with HonorHealth Expands US Momentum
- Ceasing to be a substantial holder
- Becoming a substantial holder
- Artrya 2026 Annual General Meeting - Webinar Details
- September Quarterly Activities Report and Appendix 4C
Later from Artrya
All Artrya news releasesFollow Artrya into a list and get an email when it puts out news.
Follow Artrya